GlassScriptPhysician profile
Allan C Harrington
NPI 1497723050
$2,230.35
in general payments reported to CMS, 2019-2025
19 companies · $1,490 in 2025
The $1,490 reported for 2025 was more than what 83% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2023: $120 · 2024: $437 · 2025: $1,490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,027 · Education: $21.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,026.72 |
| Education | $21.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $349.62 | 2023-2025 | Bimzelx |
| Abbvie INC. | $327.50 | 2025 | |
| Genzyme Corporation | $291.40 | 2024-2025 | |
| Janssen Biotech, INC. | $274.41 | 2025 | Tremfya |
| Vanda Pharmaceuticals INC. | $182.42 | 2019 | |
| Galderma Laboratories, L.P. | $134.70 | 2024-2025 | Nemluvio |
| Lilly USA, LLC | $127.99 | 2024-2025 | Olumiant, Taltz, Ebglyss |
| Pfizer INC. | $113.36 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $101.28 | 2025 | Libtayo, Dupixent |
| Dermavant Sciences, INC. | $70.71 | 2024 | Vtama |
| Organon LLC | $57.20 | 2025 | |
| Amgen INC. | $48.41 | 2025 | Otezla |
| Leo Pharma INC. | $32.57 | 2025 | Adbry |
| Arcutis Biotherapeutics, INC. | $23.07 | 2025 | Zoryve |
| Biofrontera INC. | $22.17 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $19.98 | 2025 | Opzelura |
| Mimedx Group, INC. | $19.72 | 2024 | |
| Strata Skin Sciences, INC. | $19.61 | 2025 | Xtrac |
| Sun Pharmaceutical Industries INC. | $14.23 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allan Harrington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.